Intco Medical’s share repurchase program nears RMB 60m mark

Intco Medical Technology Co., Ltd. has announced the progress of its share repurchase program, which commenced following resolutions passed on September 19, 2024. As of August 31, 2025, the company has cumulatively repurchased 2,703,400 shares through concentrated bidding, representing 0.4129% of its total share capital as of August 29, 2025.

The repurchases were executed at a highest price of RMB 25.44 per share and a lowest price of RMB 20.06 per share, with the total transaction amount reaching RMB 58,041,136.28, excluding transaction fees. The company had initially approved a repurchase scheme using its own funds, ranging from not less than RMB 80,000,000 to not more than RMB 120,000,000, with a price cap not exceeding RMB 26.51 per share. These repurchased shares are earmarked for employee stock ownership plans and/or equity incentives.

Intco Medical confirms that all repurchases have been conducted in compliance with its approved plan and relevant regulatory requirements. The company commits to continue implementing the repurchase plan within the stipulated period and to disclose information promptly as required by laws and regulations.